After IPO, Portola Seeks Seconds with $105.9M Public Offering
By Marie Powers
Thursday, October 17, 2013
Five months after closing its initial public offering (IPO), Portola Pharmaceuticals Inc. took advantage of the rise in its shares (NASDAQ:PTLA) to price an underwritten public offering of approximately 6.4 million shares of its common stock at $23.75 apiece.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.